Cargando…

Gastrointestinal Fistulas in Necrotizing Pancreatitis Receiving a Step-Up Approach Incidence, Risk Factors, Outcomes and Treatment

PURPOSE: Necrotizing pancreatitis (NP) complicated by gastrointestinal fistula is challenging and understudied. As the treatment of necrotizing pancreatitis changed to a step-up strategy, we attempted to evaluate the incidence, risk factors, clinical outcomes and treatment of gastrointestinal fistul...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zheyu, Ke, Huajing, Xiong, Yuwen, Liu, Hui, Yue, Mengli, Liu, Pi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676678/
https://www.ncbi.nlm.nih.gov/pubmed/38026251
http://dx.doi.org/10.2147/JIR.S433682
_version_ 1785149965760200704
author Liu, Zheyu
Ke, Huajing
Xiong, Yuwen
Liu, Hui
Yue, Mengli
Liu, Pi
author_facet Liu, Zheyu
Ke, Huajing
Xiong, Yuwen
Liu, Hui
Yue, Mengli
Liu, Pi
author_sort Liu, Zheyu
collection PubMed
description PURPOSE: Necrotizing pancreatitis (NP) complicated by gastrointestinal fistula is challenging and understudied. As the treatment of necrotizing pancreatitis changed to a step-up strategy, we attempted to evaluate the incidence, risk factors, clinical outcomes and treatment of gastrointestinal fistulas in patients receiving a step-up approach. METHODS: Clinical data from 1274 patients with NP from 2014–2022 were retrospectively analyzed. Multivariable logistic regression analysis was conducted to identify risk factors and propensity score matching (PSM) to explore clinical outcomes in patients with gastrointestinal fistulas. RESULTS: Gastrointestinal fistulas occurred in 8.01% (102/1274) of patients. Of these, 10 were gastric fistulas, 52 were duodenal fistulas, 14 were jejunal or ileal fistulas and 41 were colonic fistulas. Low albumin on admission (OR, 0.936), higher CTSI (OR, 1.143) and invasive intervention prior to diagnosis of gastrointestinal fistula (OR, 5.84) were independent risk factors for the occurrence of gastrointestinal fistula, and early enteral nutrition (OR, 0.191) was a protective factor. Patients who developed a gastrointestinal fistula were in a worse condition on admission and had a poorer clinical outcome (p<0.05). After PSM, both groups of patients had similar baseline information and clinical characteristics at admission. The development of gastrointestinal fistulas resulted in new-onset persistent organ failure, increased open surgery, prolonged parenteral nutrition and hospitalization, but not increased mortality. The majority of patients received only conservative treatment and minimally invasive interventions, with 7 patients (11.3%) receiving surgery for upper gastrointestinal fistulas and 11 patients (26.9%) for colonic fistulas. CONCLUSION: Gastrointestinal fistulas occurred in 8.01% of NP patients. Independent risk factors were low albumin, high CTSI and early intervention, while early enteral nutrition was a protective factor. After PSM, gastrointestinal fistulas resulted in an increased proportion of NP patients receiving open surgery and prolonged hospitalization. The majority of patients with gastrointestinal fistulas treated with step-up therapy could avoid surgery.
format Online
Article
Text
id pubmed-10676678
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106766782023-11-22 Gastrointestinal Fistulas in Necrotizing Pancreatitis Receiving a Step-Up Approach Incidence, Risk Factors, Outcomes and Treatment Liu, Zheyu Ke, Huajing Xiong, Yuwen Liu, Hui Yue, Mengli Liu, Pi J Inflamm Res Original Research PURPOSE: Necrotizing pancreatitis (NP) complicated by gastrointestinal fistula is challenging and understudied. As the treatment of necrotizing pancreatitis changed to a step-up strategy, we attempted to evaluate the incidence, risk factors, clinical outcomes and treatment of gastrointestinal fistulas in patients receiving a step-up approach. METHODS: Clinical data from 1274 patients with NP from 2014–2022 were retrospectively analyzed. Multivariable logistic regression analysis was conducted to identify risk factors and propensity score matching (PSM) to explore clinical outcomes in patients with gastrointestinal fistulas. RESULTS: Gastrointestinal fistulas occurred in 8.01% (102/1274) of patients. Of these, 10 were gastric fistulas, 52 were duodenal fistulas, 14 were jejunal or ileal fistulas and 41 were colonic fistulas. Low albumin on admission (OR, 0.936), higher CTSI (OR, 1.143) and invasive intervention prior to diagnosis of gastrointestinal fistula (OR, 5.84) were independent risk factors for the occurrence of gastrointestinal fistula, and early enteral nutrition (OR, 0.191) was a protective factor. Patients who developed a gastrointestinal fistula were in a worse condition on admission and had a poorer clinical outcome (p<0.05). After PSM, both groups of patients had similar baseline information and clinical characteristics at admission. The development of gastrointestinal fistulas resulted in new-onset persistent organ failure, increased open surgery, prolonged parenteral nutrition and hospitalization, but not increased mortality. The majority of patients received only conservative treatment and minimally invasive interventions, with 7 patients (11.3%) receiving surgery for upper gastrointestinal fistulas and 11 patients (26.9%) for colonic fistulas. CONCLUSION: Gastrointestinal fistulas occurred in 8.01% of NP patients. Independent risk factors were low albumin, high CTSI and early intervention, while early enteral nutrition was a protective factor. After PSM, gastrointestinal fistulas resulted in an increased proportion of NP patients receiving open surgery and prolonged hospitalization. The majority of patients with gastrointestinal fistulas treated with step-up therapy could avoid surgery. Dove 2023-11-22 /pmc/articles/PMC10676678/ /pubmed/38026251 http://dx.doi.org/10.2147/JIR.S433682 Text en © 2023 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Zheyu
Ke, Huajing
Xiong, Yuwen
Liu, Hui
Yue, Mengli
Liu, Pi
Gastrointestinal Fistulas in Necrotizing Pancreatitis Receiving a Step-Up Approach Incidence, Risk Factors, Outcomes and Treatment
title Gastrointestinal Fistulas in Necrotizing Pancreatitis Receiving a Step-Up Approach Incidence, Risk Factors, Outcomes and Treatment
title_full Gastrointestinal Fistulas in Necrotizing Pancreatitis Receiving a Step-Up Approach Incidence, Risk Factors, Outcomes and Treatment
title_fullStr Gastrointestinal Fistulas in Necrotizing Pancreatitis Receiving a Step-Up Approach Incidence, Risk Factors, Outcomes and Treatment
title_full_unstemmed Gastrointestinal Fistulas in Necrotizing Pancreatitis Receiving a Step-Up Approach Incidence, Risk Factors, Outcomes and Treatment
title_short Gastrointestinal Fistulas in Necrotizing Pancreatitis Receiving a Step-Up Approach Incidence, Risk Factors, Outcomes and Treatment
title_sort gastrointestinal fistulas in necrotizing pancreatitis receiving a step-up approach incidence, risk factors, outcomes and treatment
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676678/
https://www.ncbi.nlm.nih.gov/pubmed/38026251
http://dx.doi.org/10.2147/JIR.S433682
work_keys_str_mv AT liuzheyu gastrointestinalfistulasinnecrotizingpancreatitisreceivingastepupapproachincidenceriskfactorsoutcomesandtreatment
AT kehuajing gastrointestinalfistulasinnecrotizingpancreatitisreceivingastepupapproachincidenceriskfactorsoutcomesandtreatment
AT xiongyuwen gastrointestinalfistulasinnecrotizingpancreatitisreceivingastepupapproachincidenceriskfactorsoutcomesandtreatment
AT liuhui gastrointestinalfistulasinnecrotizingpancreatitisreceivingastepupapproachincidenceriskfactorsoutcomesandtreatment
AT yuemengli gastrointestinalfistulasinnecrotizingpancreatitisreceivingastepupapproachincidenceriskfactorsoutcomesandtreatment
AT liupi gastrointestinalfistulasinnecrotizingpancreatitisreceivingastepupapproachincidenceriskfactorsoutcomesandtreatment